Future Forward: Innovation at the Intersection

BioCardia’s innovative cell therapy for heart failure receives a crucial FDA signal, potentially paving the way for a new treatment paradigm for millions.

A new drug promises the brain-rewiring benefits of psychedelics without the trip. Can Clearmind Medicine's CMND-100 transform addiction treatment?

As autonomous AI agents gain unprecedented power in corporations, a critical governance crisis looms. Devenex, from the enterprise veterans at Abacus, has an answer.

As TopBuild shareholders face a critical merger deadline, QXO is assembling an industry titan. This move isn't just about size; it's a bid to reshape the future.

Amid market turbulence, LoCorr bets on a dual talent strategy, hiring a veteran distributor and new graduates to meet surging demand for alternative investments.

TRUFF and PopUp Bagels' new schmear is more than a snack; it's a masterclass in modern marketing, blending scarcity, celebrity, and logistical savvy.

A new podcast, The Golden Ball, teams a World Cup star with Jungian experts to explore how soccer's drama offers a powerful playbook for personal growth.

Hivemind Capital and UC Berkeley launch darkmatter lab, a novel model to inject capital and resources into frontier research before it becomes a company.

A fully funded drill program in Saskatchewan's rich Athabasca Basin showcases a clever partnership and the urgent, global race for clean nuclear energy.

Forget the cloud. A new wave of powerful mini PCs is bringing AI processing home, offering users unprecedented privacy, speed, and independence from subscriptions.

As Saskatchewan prepares to add a 71st name to its impaired driving memorial, the ceremony highlights a painful past and a future where technology and advocacy converge.

As CityCentre expands, a new AC Hotel brings a refined, modern hospitality concept, reflecting the evolving demands of today's urban traveler.

An ex-timeshare salesman’s crisis of conscience sparked a new venture. Now, his son-in-law's firm is using that insight to help thousands escape costly contracts.

A new partnership uses healthcare data expertise to guide military caregivers through a mental health crisis. But is this innovative solution enough?

As companies pour billions into AI, a new report reveals a critical flaw: only 19% of employees feel confident using it, fueling a 'readiness recession'.

Canadian innovator Barkman Concrete enters the US via a deal with PNW giant Mutual Materials. A deep dive into the strategy and market impact.

The struggling biopharma secures cash, but its creative financing deal could dilute existing shareholder value by over 30%. A deep dive into the high-stakes world of biotech funding.

UGI Corporation hit its 2025 ESG goals early. We dive into the innovations—from RNG to AI governance—that set a new standard for the energy sector.

JohnsByrne's new sustainability report reveals impressive green metrics, but what does it mean for the luxury market? We explore how innovation is solving the premium paradox.

FDA clearance for Pulmera's CBeam platform could democratize surgery by turning standard 2D X-ray machines into advanced 3D imagers, slashing costs.